Sharon Bio-Medicine gets nod from EDQM for Plant at Taloja in Navi Mumbai

Sharon Bio-Medicine’s Active Pharma Ingredient manufacturing Plant at Plot No. L-6, MIDC, Taloja, near Navi Mumbai District  Raigad, Maharashtra has been approved by European Directorate for the Quality of Medicines & Healthcare (EDQM) Council of Europe for complying with the certificate of suitability, as well as the implementation of a suitable Quality Management System based on the Good Manufacturing Practice as laid down in the EU Rules governing Medicinal Product in the European Union, the Company operates in accordance with the requirements of the Resolution AP-CSP (07) 1.  Earlier, the company had completed expansion in its three manufacturing facilities. The total investment in expansion has been incurred to the tune nearly Rs 125 crore. In Dehradun Formulation plant, the expanded expenditure has been around Rs 85 crore whereas capacity of the plant has been increased more than double. Similarly, other plants’ capacity had been added between 30-50%. Sharon Bio-Medicine’s Toxicology Laboratories is an independent cost centre and is approved by Department of Science & Technology, Government of India. Government of India has approved Good Laboratory Certificate to SA-FORD which is valid as per OECD Countries - GLP studies.